Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Sequential Icotinib Plus Chemotherapy
Betta Pharmaceuticals Co.,
EGFR Positive Non-small Cell Lung Cancer
1 trial -
SomaKit TOC 40 micrograms kit for radiopharmaceutical preparation
Ningbo Cancer Hospital
Gastroenteropancreatic neuroendocrine tumors
1 trial -
TAGRISSO 80 mg film-coated tablets
Disc Medicine
EGFR mutated locally advanced or metastatic non-small cell lung cancer
1 trial -
TAGRISSO 80 mg film-coated tablets
Disc Medicine
EGFR mutated locally advanced or metastatic non-small cell lung cancer
1 trial -
TAMOXIFEN
Disc Medicine
Breast cancer
1 trial -
TILMANOCEPT, TILMANOCEPT, GALLIUM (68GA) CHLORIDE, TECHNETIUM (99MTC)
Disc Medicine
Oral cancer
1 trial -
Talzenna 1 mg hard capsules
Disc Medicine
Breast cancer
1 trial -
Thalidomide
The First People's Hospital of Lianyungang
Gastric Cancer
1 trial -
Toripalimab
Coherus Oncology
Nasopharyngeal Cancer Recurrent
1 trial -
Tramadol HCI/acetaminophen
Janssen-Cilag Pty Ltd
Cancer
1 trial -
Trastuzumab Rezetecan
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Xofigo 1100 kBq/mL solution for injection, DELTACORTENE 5 mg compresse, ZYTIGA 500 mg film-coated tablets, Xtandi - 40 mg soft capsules, Prednisolone 5mg Tablets
Bayer AG
metastatic castrate resistant prostate cancer (mCRPC)
1 trial -
Xtandi - 40 mg soft capsules
The George Institute
PROSTATE CANCER
1 trial -
aspirin and/or clopidogrel
Takeda
Early Gastric Cancer
1 trial -
docetaxel
Hoffmann-La Roche
Breast Cancer
2 trials -
silk suture
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
trastuzumab [Herceptin]
Hoffmann-La Roche
Gastric Cancer
1 trial -
89Zr-trastuzumab
United Therapeutics Europe Ltd
Breast Cancer Metastases
1 trial -
Accelerated partial breast irradiation
Universal Integrated
Breast Cancer
1 trial -
Accurate Prediction Artificial Intelligence Models
The First People's Hospital of Lianyungang
Prostate Cancer
1 trial -
Akkermansia Probiotics
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Colo-rectal Cancer
1 trial -
Albumin paclitaxel/neutrophil drug
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Breast Cancer
1 trial -
Anlotinib hydrochloride
The First People's Hospital of Lianyungang
Non-Small-Cell Lung Cancer
2 trials -
Artificial Intelligence Enabled Transvaginal Ultrasound Imaging algorithm
The First People's Hospital of Lianyungang
Ovarian Cancer
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources